Literature DB >> 18768517

Associations of lifestyle and physiologic factors with prostate-specific antigen concentrations: evidence from the National Health and Nutrition Examination Survey (2001-2004).

Niyati Parekh1, Yong Lin, Stephen Marcella, Ashima K Kant, Grace Lu-Yao.   

Abstract

Studies suggest inverse associations between obesity and prostate-specific antigen (PSA). However, there is little evidence whether factors related to obesity, including lifestyle (diet and physical activity) and physiologic factors (insulin resistance and metabolic syndrome), influence PSA. We used dietary, physical activity, and serum PSA, insulin, glucose, and lipid data for men >40 years from the National Health and Nutrition Examination Survey (2001-2004; N = 2,548). Energy, fat, and carbohydrate intakes were estimated from a 24-hour dietary recall. Men were considered as having metabolic syndrome based on the Adult Treatment Panel III criteria. Leisure-time physical activity and doctor-diagnosed hypertension were self-reported. Body mass index was calculated from measured weight and height. We computed the geometric mean PSA (ng/mL), adjusted for age, race, and body mass index, by tertile of energy, fat, and carbohydrate intake and level of physical activity, and among men with and without insulin resistance and metabolic syndrome in the whole population and by race. The geometric mean PSA (95% confidence interval) among men in the lowest tertile of energy was 1.05 (0.97-1.1) relative to 0.85 (0.8-0.9) in the highest tertile (P = 0.0002) in the whole population. The PSA concentrations were lower among overweight men with higher versus lower energy intake (P = 0.001). The PSA concentrations in men with insulin resistance was lower [0.87 (0.8-0.9)] relative to men without insulin resistance [0.98 (0.9-1.1)] at P = 0.04. All associations were in similar directions within racial subgroups. No associations were observed between the other lifestyle and physiologic factors. Additional studies are required to confirm these results and to investigate the potential mechanisms that may explain these relationships.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18768517      PMCID: PMC2822540          DOI: 10.1158/1055-9965.EPI-08-0059

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  24 in total

1.  Total and free PSA serum concentrations are not influenced by extensive physical exercise and bicycle riding.

Authors:  G Lippi; A Corgnati; G Salvagno; F Schena; M Franchini; G Guidi
Journal:  Int J Sports Med       Date:  2005 Jan-Feb       Impact factor: 3.118

2.  Radical prostatectomy: transrectal sonographic evaluation to assess for local recurrence.

Authors:  C G Salomon; M E Flisak; M C Olson; C M Dudiak; R C Flanigan; W B Waters
Journal:  Radiology       Date:  1993-12       Impact factor: 11.105

3.  Observed effect of age and body mass index on total and complexed PSA: analysis from a national screening program.

Authors:  Al Baha Barqawi; Brian K Golden; Colin O'Donnell; Michael K Brawer; E David Crawford
Journal:  Urology       Date:  2005-04       Impact factor: 2.649

4.  The association of body mass index and prostate-specific antigen in a population-based study.

Authors:  Jacques Baillargeon; Brad H Pollock; Alan R Kristal; Patrick Bradshaw; Javier Hernandez; Joseph Basler; Betsy Higgins; Steve Lynch; Thomas Rozanski; Dean Troyer; Ian Thompson
Journal:  Cancer       Date:  2005-03-01       Impact factor: 6.860

5.  Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.

Authors:  D R Matthews; J P Hosker; A S Rudenski; B A Naylor; D F Treacher; R C Turner
Journal:  Diabetologia       Date:  1985-07       Impact factor: 10.122

6.  Interrelation between plasma testosterone and plasma insulin in healthy adult men: the Telecom Study.

Authors:  D Simon; P Preziosi; E Barrett-Connor; M Roger; M Saint-Paul; K Nahoul; L Papoz
Journal:  Diabetologia       Date:  1992-02       Impact factor: 10.122

7.  Dietary manipulation, ethnicity, and serum PSA levels.

Authors:  James A Eastham; Elyn Riedel; Lianne Latkany; Martin Fleisher; Arthur Schatzkin; Elaine Lanza; Moshe Shike
Journal:  Urology       Date:  2003-10       Impact factor: 2.649

8.  Lack of effect of a low-fat, high-fruit, -vegetable, and -fiber diet on serum prostate-specific antigen of men without prostate cancer: results from a randomized trial.

Authors:  Moshe Shike; Lianne Latkany; Elyn Riedel; Martin Fleisher; Arthur Schatzkin; Elaine Lanza; Donald Corle; Colin B Begg
Journal:  J Clin Oncol       Date:  2002-09-01       Impact factor: 44.544

9.  Demographic and clinical factors as determinants of serum levels of prostate specific antigen and its derivatives.

Authors:  Marion A Gray; Brett Delahunt; Jefferson R Fowles; Philip Weinstein; Russell R Cookes; John N Nacey
Journal:  Anticancer Res       Date:  2004 May-Jun       Impact factor: 2.480

10.  Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer.

Authors:  Lionel L Bañez; Robert J Hamilton; Alan W Partin; Robin T Vollmer; Leon Sun; Carmen Rodriguez; Yiting Wang; Martha K Terris; William J Aronson; Joseph C Presti; Christopher J Kane; Christopher L Amling; Judd W Moul; Stephen J Freedland
Journal:  JAMA       Date:  2007-11-21       Impact factor: 56.272

View more
  9 in total

1.  The effects of type 2 diabetes and hypertension on changes in serum prostate specific antigen levels: results from the Olmsted County study.

Authors:  Lauren P Wallner; Hal Morgenstern; Michaela E McGree; Debra J Jacobson; Jennifer L St Sauver; Steven J Jacobsen; Aruna V Sarma
Journal:  Urology       Date:  2010-11-20       Impact factor: 2.649

2.  Our shifting understanding of factors influencing prostate-specific antigen.

Authors:  Eric A Singer; Robert S DiPaola
Journal:  J Natl Cancer Inst       Date:  2013-08-13       Impact factor: 13.506

3.  Associations of serum vitamin A and carotenoid levels with markers of prostate cancer detection among US men.

Authors:  Hind A Beydoun; Monal R Shroff; Ravinder Mohan; May A Beydoun
Journal:  Cancer Causes Control       Date:  2011-07-29       Impact factor: 2.506

4.  Association between C-peptide concentration and prostate cancer incidence in the CLUE II cohort study.

Authors:  Gabriel Y Lai; Kathy J Helzlsouer; Sandra L Clipp; Nader Rifai; Elizabeth A Platz
Journal:  Cancer Prev Res (Phila)       Date:  2010-09-21

5.  Metabolic dysregulation of the insulin-glucose axis and risk of obesity-related cancers in the Framingham heart study-offspring cohort (1971-2008).

Authors:  Niyati Parekh; Yong Lin; Maya Vadiveloo; Richard B Hayes; Grace L Lu-Yao
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-09-24       Impact factor: 4.254

6.  Impact of metabolic syndrome on response to medical treatment of benign prostatic hyperplasia.

Authors:  Ali Cyrus; Ali Kabir; Davood Goodarzi; Afsaneh Talaei; Ali Moradi; Mohammad Rafiee; Mehrdad Moghimi; Elham Shahbazi; Elaheh Farmani
Journal:  Korean J Urol       Date:  2014-12-05

7.  Studying the effect of type 2 diabetes mellitus on prostate-related parameters: A prospective single institutional study.

Authors:  Ahmed Elabbady; Mohamed M Hashad; Ahmed F Kotb; Ali E Ghanem
Journal:  Prostate Int       Date:  2016-08-03

8.  Association of Total Dietary Intake of Sugars with Prostate-Specific Antigen (PSA) Concentrations: Evidence from the National Health and Nutrition Examination Survey (NHANES), 2003-2010.

Authors:  Zhangcheng Liu; Chi Chen; Fuxun Yu; Dongbo Yuan; Wei Wang; Ke Jiao; Shengbang Yang; Yongqiang Zhang; Yong Wang; Linhai Liu; Huali Xu; Yang Zhang; Guohua Zhu; Bin Hu; Jianguo Zhu
Journal:  Biomed Res Int       Date:  2021-01-09       Impact factor: 3.411

9.  The association of pathogenic factors of metabolic syndrome on serum prostate-specific antigen levels: a pilot study.

Authors:  Bo-Wen Xia; Si-Cong Zhao; Zong-Ping Chen; Chao Chen; Tian-Shu Liu; Fan Yang; Yong Yan
Journal:  BMC Urol       Date:  2019-11-21       Impact factor: 2.264

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.